News Details

( 06/08/2018 10:28)
Sun Pharma slips over 1% on drug recalling

Shares of Sun Pharmaceutical Industries fell over 1 per cent on the Bombay Stock Exchange after media report suggested that the drug maker’s US arm is recalling over 5.2 thousand units of testosterone cypionate injections from the American market.

Reacting to the news, stocks of the company declined as much as 1.15 per cent and touched an intra-day low of Rs 578.10 apiece on the Bombay Stock Exchange.

In a similar trend, shares of the firm were trading 1.05 per cent lower at Rs 579.70 apiece on the National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 37,697.25, up 141.09 points, or 0.38 per cent, from previous close on the BSE at 10:25 hours.

ATTENTION INVESTORS 1 : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case | 2 : "Prevent Unauthorized Transactions in your demat / trading account --> Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors. | 3 : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

SEBI Regn. NSE: INB231280430 I F&O: INF231280430 I BSE: INB011280436 I NSE CD: INE231280430 I MCX-SX: INE261280430

Copyright © 2017 Rikhav Securities Ltd. All rights reserved

Designed , Developed & Content Powered by DION